←
Tevard Biosciences101 posts
Tevard Biosciences avatar

Tevard Biosciences

@TevardB
◷ Joined November 2020▧ 45 Photos and videos
Tevard Biosciences avatar
Tevard Biosciences@TevardB·14 Nov 2025

Excited our CSO, Elisabeth Gardiner, is featured in The Medicine Maker on tRNA therapeutics that restore protein in diseases like #DMD and #DCM. Read more: tinyurl.com/yvnrnt35 #Biotech #tRNAtherapy #RareDisease

Tevard Biosciences avatar
Tevard Biosciences@TevardB·29 Sep 2025

Tevard CSO Elisabeth Gardiner presented data at FEBS demonstrating the power of Tevard’s suppressor tRNA (suptRNA) platform to rescue full-length, functional proteins in both Duchenne muscular dystrophy (DMD) and dilated cardiomyopathy caused by titin truncations (DCM-TTNtv).

0:20
Tevard Biosciences avatar
Tevard Biosciences@TevardB·7 Sep 2025

Today, on #WorldDuchenneAwarenessDay, we honor the courage of patients and families facing the daily realities of #DMD. At Tevard, we’re developing tRNA-based gene therapies to address nonsense mutations—aiming to restore dystrophin & support healthy muscle function.

0:06
Tevard Biosciences avatar
Tevard Biosciences@TevardB·5 Sep 2025

In this podcast, our CEO @Daniel Fischer and @David Wild discuss our unique approach to gene therapy, the technology, and advantages it offers over traditional methods. You’ll also learn more about our lead programs and near-term milestones! insights.citeline.com/in-viv…

Tevard Biosciences avatar
Tevard Biosciences@TevardB·3 Sep 2025

Don’t forget to register for this impactful event and the discussion of an all-star panel talking about Therapeutic Modalities & Their Relevance to Your Disease.  There's still time to register and live stream today's sessions! Register now: lnkd.in/eBwAC3fe

Post attachment
Tevard Biosciences avatar
Tevard Biosciences@TevardB·19 Aug 2025

Hear our co-founder and leader Daniel Fischer on how ‘recovering what’s lost in translation’, is central to our approach to gene therapy to restore vital protein production and deliver life-changing therapies for rare diseases caused by nonsense mutations.

Daniel Fischer of @TevardB discusses his journey as the parent of a child with a rare disease, how it led to his co-founding Tevard, and its pursuit of tRNA therapies that may treat a range of diseases with a single medicine. @GlobalGenes #RARECast globalgenes.org/raredaily/re…

Tevard Biosciences avatar
Tevard Biosciences@TevardB·12 Aug 2025

Register now and don’t miss this session at @GlobalGenes RARE Drug Development Symposium where our CEO Daniel Fischer will join a panel to discuss: 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗠𝗼𝗱𝗮𝗹𝗶𝘁𝗶𝗲𝘀 & 𝗧𝗵𝗲𝗶𝗿 𝗥𝗲𝗹𝗲𝘃𝗮𝗻𝗰𝗲 𝘁𝗼 𝗬𝗼𝘂𝗿 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 globalgenes.tfaforms.net/502…

Post attachment
Tevard Biosciences avatar
Tevard Biosciences@TevardB·6 Aug 2025

🚀Congrats to Teerith Pasricha, Victoria Rose, Sophia Zheng, Viggo Blomquist and Steffany Villasenor who are “graduating” from Tevard to pursue PhDs! Thanks for the visit from Tevard co-founder/mentor Harvey Lodish. Excited to see what they’ll do next!

Post attachment
Tevard Biosciences avatar
Tevard Biosciences@TevardB·1 Aug 2025

🧬 Happy tRNA Day! We’re pioneering tRNA-based therapies to fix nonsense mutations—restoring full-length protein function and offering hope for patients with rare genetic diseases once thought untreatable. Small molecule, big impact!

Post attachment
Tevard Biosciences avatar
Tevard Biosciences@TevardB·30 Jun 2025

👏 Thanks to @edsilverman and @statnews for highlighting our new CSO, Elisabeth Gardiner. We’re excited to have her join us to advance our tRNA platform to cure rare genetic diseases. 🚶‍♀️ Learn more about Elisabeth here: tinyurl.com/ytk4w98w #tRNA #RareDisease